Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Guanxin Danshen Dripping Pills
- Development stage
- Phase 4
- Lead developer
- Buchang Pharmaceuticals
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral, Sublingual
01
Overview
Guanxin Danshen Dripping Pills is a Traditional Chinese Medicine (TCM) product widely used in China for the treatment of cardiovascular diseases, particularly coronary artery disease (CAD) and angina pectoris. The formulation typically includes extracts from *Salvia miltiorrhiza* (Danshen), *Panax notoginseng* (Sanqi), and *Dalbergia odorifera* (Jiangxiang). It is designed to promote blood circulation, resolve blood stasis, and regulate qi to alleviate pain. The dripping pill dosage form is a modern TCM preparation that enhances bioavailability and allows for rapid absorption, often used for both chronic management and acute relief of chest pain. Clinical studies have expanded its investigation into the treatment of CAD patients with comorbid psychological distress, such as depression and anxiety, exploring its potential systemic anti-inflammatory and neuroprotective effects.
- Brand names
- Guanxin Danshen Dripping Pills
- Other names
- Guanxin Danshen Diwan
02
Targets
NOS3 (eNOS)PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)NOS1 (nNOS)COX
Beyond the preview
Go deeper on Guanxin Danshen Dripping Pills.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Guanxin Danshen Dripping Pills.